Since TRXC bought ALF, it's stock has plummeted. I guess that means investors don't think TRXC has much to offer. If there was value in that purchase, the stock price would have moved north. Good indication that the market is looking for the next surgical robotic platform to be innovative like Titan SPORT TITXF.

You shouldn't be laughing so much since you've lost so much on TRXC and obviously you don't know what you are talking about with FDA approval. Also, you obviously don't research or read links that people post so I am going to help you out. Here is that link (which was posted on this board just a couple of days ago), open it, read thru it and it has a hyperlink on adaptive design - it's informational since you are "invested in this space" and its your obligation "to know everything in it". THIS LINK IS FROM THE FDA not some "anonymous" author on SeekingAlpha or one of those sites.

Just a quick quote from the article from the FDA
"We've also issued a draft guidance that, when final, will ENCOURAGE THE USE OF ADAPTIVE DESIGNS FOR CLINICAL TRIALS"

http://blogs.fda.gov/fdavoice/index.php/2015/09/strengthening-the-clinical-trial-enterprise-for-medical-devices-an-fdacdrh-strategic-priority-update/

Adpative Design is a key component of what Ximedica does and it is exactly what TRXC does not have. Just do a little research LTG. I can't imagine anyone who is invested in TRXC that is "LMAO".

LTG, one thanks for proving my point that you don't understand that if they sell Outside US it is still revenue (which will come in 2016 - see timeline). Also, you are completely wrong LTG on design and submission to FDA - Look up adaptive design during Early Feasbility testing and clinical trials - what I am 99% sure is that Titan and Ximedica have built this in to their submission process which allows for changes during the process. I am 99% sure that TRXC has not built this in to their submission process - evident by the fact that they were supposed to have FDA approval in 2015, which they won't probably due to a redesign (b/c they probably didn't have the foresight to apply adaptive design request) and now they go out and buy an intuitive knockoff

IMO, Titan is ahead of schedule. I'm willing to bet $14 (which was the price of TRXC stock a year ago and it went down to $2.50 on Friday after the announcement they purchased ALF ) that SPORT will have revenue before Surgibot.

Great to see Ximedica and Aidan Petrie being major sponsors/contributors to a huge robotics conference

http://globenewswire.com/news-release/2015/09/22/770103/0/en/IDSA-IDSAMedical15-to-Explore-Latest-in-Medical-Design.html

By the way, it will be 2020 before TRXC sees PPS back to $14 which is where it was trading a year ago. IMO Titan will have CE before Surgibot/80's TV show have FDA.

Looks like they will generate revenue in 2016, Commercial Launch in 2016 (apparently some poeple on this board - LTG - don't think revenue counts if it is not domestic)

http://www.titanmedicalinc.com/milestones/

TRXC - uh-oh

IMO, i think Titan and SPORT are ahead of schedule.

http://blogs.fda.gov/fdavoice/index.php/2015/09/strengthening-the-clinical-trial-enterprise-for-medical-devices-an-fdacdrh-strategic-priority-update/

Trxc mgmt also said surgibot would have fda approval in 2015

A couple of months...these types of things don't happen in a "Couple of months".

Here you go hospital executive, you have to buy two completely different platforms with completely different tools and completely different training programs and two completely different maintenence/service contracts. Oh and by the way, one will cost you just as much as the davinci and we will charge you an add'l half a million for another one b/c we need to unload it since we spent 1/2 decade developing it.

Good luck

if they thought Surgibot was a game changer, why go out an buy an entirely new surgical robotic platform? Also, its obvious TRXC has been looking at an alternative to surgibot b/c a deal like this doesn't happen overnight. They probably been looking once the PPS plummeted from $14/share to $3/share.

And yes, IMO I do believe TRXC with the advice of Laviolette looked at Titan, couldn't get it and began looking at another alternative (surgibot wasn't going to cut it). Also could be a possible explanation for the purchase of Ximedica by SV lifesciences by Laviolette.

TITXF They will be showcasing their technology on October 24.

LTG, we know you are not in healthcare, but how does a value analysis committee approve Alf/Transenterix when it is the same cost of davinci and same technology (or a step back in technology)? It is not going to happen

Also, how will TRXC now manufacture two completely different end effectors?

IMO, TRXC and Laviollette made a play for Titan (b/c they knew Surgibot was not going to be well rec'd by market). Titan rejected the offer and also put a shareholder rights plan in place to protect themselves. TRXC was now stuck and had to go with a plan B which was buying ALF.

Will be curious to see what happens to the stock price of TRXC.

If a hospital can buy either ALF or Surgibot for the same price, why would you buy both? Seems to me that there is a ton of problems with Surgibot and TRXC knows it. IMO, they don't get FDA approval of Surgibot in Q1 or Q2 or Q3.

Also, how long before this TRXC/Alf gets the stock up to $14 which was the high for the stock? TRXC still trading at all time lows, obviously Surgibot is DOA (otherwise you don't purchase an entirely new platform). Lot of dead money in TRXC with more dilution on the way. They also forbid any sell of the stock for 1 and 2 year which sheds light that TRXC is a long way from becoming profitable, will probably need to get to $20/share for many people to make money on this product.

FDA approval for ALF is minimum 3 years away and surgibot will never make it to make and if it does, hospitals will have to buy 2 systems and take up twice the space if they buy ALF and Surgibot - cost prohibitive and will gain no traction.

Good thing TITXF will be a single port and multi-port in one surgical robotic system.

TRXC was once $14/share now trading at $2.60/share and appears to be heading down with this acquisition since neither of these products are FDA approved. Go check out how much revenue ALF has since they got CE mark 10 years ago.

This is great news for Titan. Obviously no way that Warren Robotics will be looking at Alf/Transenterix which means one of two things: either Warren Robotics is developing their own (hard to believe that if JJDC owns 24.6% of Warren Robotics) or they will acquire a surgical robotics platform on their own.

IMO, this only enhances the possibility that Warren Robotics will take a serious look at Titan Medical ($TITXF).

Would this not indicated a design freeze?

Weird how Everything at that conf was 15 minutes.

That is good news though and we should see more than just a CAD drawing - I will be interested if this is the unveiling or if something will come out b/t now and Oct. 24.

http://www.newindianexpress.com/cities/kochi/Robotic-Surgery-Gaining-Popularity/2015/09/17/article3032123.ece

The problem I have with your argument is that you say we can't compare it to Apple or Amazon or these big conglomerates THEN you also say we can't compare it to ISRG. I want to invest in the next great growth area and in healthcare, robotic surgery is it. Smart investors regardless of their area of preference will always move some money to areas that represent great growth areas. NOW, I am fully aware that no big money investors will touch this until it is uplifted and to IITF point, shows progress in the platform.

"Yes Chuck, I would like to make a deal for what's behind all three doors"

Interesting you mention that b/c myself and I know of at least 13 other people who are new investors to the stock market that have invested in Titan medical over the last 12 months. Not one of them was invested in Intuitive or knew much about daVinci but understood the incredible growth in the robotic surgical market. What we understood is that once a market segment (in this case surgical robotics) that is in its infancy and is set to explode, you have to understand the risk and take a chance. we don't get many chances to invest in huge growth opportunities in their infancy (i.e. PC market, computer software, etc). I also believe that within 5-10 years, there will be multiple competitors in this segment. Red Ocean/Blue Ocean - robotic surgery is Blue Ocean with one dominant player. Atari dominated video games for 7-9 years and was the dominant player until game changing technology made it obsolete. Will Intuitive be around in 5-10 years, sure. Will they be the dominant player in the market, I'm not so sure about that.

While I wouldn't go around saying Titan will be $150/share in 3-5 years (b/c I believe they will be acquired and never get to that level), I also wouldn't say that it won't happen. One thing that I do believe, whoever gets to the market next with a game changing technology in robotic surgery (and it will happen), that company will make many people wealthy and many investors will flock to that stock regardless of their past investing tendencies.

Totally disagree with the new investors point: one of the main reasons there is so much volatility in the market is that there are more and more people taking control over their own money and investing it themselves rather than thru funds or using a financial advisor. Many "regular" people (not day traders or advisors) have rolled over previous 401(k)'s from other jobs into IRA's that they are now taking more risk with their money and investing in companies like Titan. Everyone one on this board either knows people doing this or has done it themselves. The number of new investors will only increase over time which is contrary to your point that there will be no new investors. its possible, Most of the investors on this board have probably rolled a 401k into an IRA and bought Titan with that money (all new investors)

First I never said it would be $200/share. I just disagree with your assessment of the marketplace and that no new investors will invest. I've seen $17b, $20b, $22b market in 5 years from all types of sources. Google articles about robotic surgery in India for example, let alone other countries (ie Japan, UK, etc) and u will read about the rapid adoption of robotic surgery.

Anyone in healthcare knows the priority in robotics and it's just the tip of the iceberg.

I'd be happy to have this stock hit $3 by end of q4, hit $8-10 by q4 2016/q1 2017 (outside U.S. Commercializations) and from then on its all gravy.

I actually believe the market will be bigger than $20b by 2020. Surgical robotics procedures are growing double digits year over year. Also, IMO FDA will not reign it in, why have a huge brain storm session about how to proceed if they will reign it in? Also, why is Google/ jnj getting into it if it isn't going to explode? If anyone makes an investment decision w their money based off Geo2014 or anyone else says will probably not make as much as doing their own due diligence. Imo Geo2014 is off in his assessment of the surgical robotic market.

For the board, Theorem clinical research: possible CRO for trials.

Also, Amazon makes almost no profit and their stock price is north of $500, not all PPS is based off profit.

Im sorry, ISRG's CURRENT market cap is $19.02B, not $20B

http://finance.yahoo.com/q?s=ISRG&ql=1

GEO2014, how i got that info was by going to Yahoo Finance and looking up ISRG's financial info. How do you go about getting your info?

One more point about investors, Titan will obviously be a game changing surgical robotic platform that will draw traditional healthcare investors but it will also be a play for traditional technology investors (remember fowler said that all updates will be software related). The top 2 priority budget items for healthcare today (and for the foreseeable future) are Software and Robotics. Titan combines the two.

$TITXF

Also, ISRG has a market cap of $20B right now (roughly) on $3B in sales. The robotics market will be $20B in 5 years. Say ISRG has $10B in sales, their market cap will be roughly $70B and another competitor like Titan with $5B in revenue will have a market cap of $30B.

So it won't work in the robotics market but it works in the software/computer industry? I don't follow the logic of: for one company to be successful another has to fail. The market has shown that several companies can be successful in the same industry.

You are right, I would rephrase it just like that.

no i'm not. i'm a guy who believes in Titan and has researched the Sh.t out of Titan, the robotics market, etc to the point that I'm disgusted with the amount of time I waste doing it. I also am not going to let some people just bash it b/c they want to drive it down b/c they want to day trade it.

This whole thing is one gigantic puzzle with many pieces and some of the pieces have been shared on this board but some haven't. I am also positive that there are some people on this board that have researched and uncovered info that haven't shared it with this board.

I am not concerned about anyone else's investment but my own

Do you read the board? That is not the consensus that I get.

If you knew what I know you'd hold a lot of $TITXF

IMO, this job posting and some previous job postings just confirm that JnJ is not building their own surgical robotic platform. So who is it that JnJ (more specifically JJDC) bringing to the Warren Robotics partnership with Google? $TITXF

whats your take on that?

Samsung is old news, was posted on this board @ 8-12 months ago

What happens if someone sells out and hopes it goes to a buck so they can buy back in BUT Titan $titxf is sold? Well they get screwed bc they listened to HC. It's a choice you have to make for yourselves.

I would not take HC advice bc IMO a potential M&A could happen very quickly. The next domino for me is US approval of Warren Robotics

PumperADay92, that really sounds like something someone would post if they were uneducated on Titan. $titxf

My confidence in this has gone up since watching the video and I agree with the advice to watch it 3-4 times if you are a stockholder. There is a tremendous amount of valuable info in it that help piece the puzzle together for informed investors. Obviously the big elephant is M&A and who it will be, one thought for the board that IMO is a strong possibility is ISRG coming in with a big offer. If anyone would pay a premium, it would be ISRG with the simple premise of maintaining market share, market leader position with a next generation robotic platform. It would put the competitors trying to come to market behind again and if ISRG would come in and steal Titan from a Jnj/Google Warren Robotics then it could set Warren robotics back significantly.

TRXC was at $14/share and now it is $2.75/ share w more dilution coming. Heard it hear first, Titan will sell a SPORT before TRXC sells a stickbot